ABSTRACT
Se presenta una serie de pacientes pediátricos en los que se utilizó interferón alfa-2b tópico como tratamiento coadyuvante para el papiloma conjuntival. Los papilomas conjuntivales se asocian frecuentemente a infección por virus del papiloma humano. La información en población pediátrica del uso de interferón para el tratamiento de estas lesiones es escasa. En esta serie de casos, el tratamiento adyuvante con interferón alfa 2 b tópico en pacientes pediátricos demostró ausencia de recurrencia y buena tolerancia
A series of paediatric patients is presented in whom topical interferon alpha-2b was used as a co-adjuvant treatment for conjunctival papilloma. This condition is frequently associated with human papillomavirus infection. There is little information on the pediatric population with the use of interferon for the treatment of these lesions. In this case series, adjuvant treatment with topical interferon alpha-2 b in paediatric patients showed no recurrence and good tolerance
Subject(s)
Humans , Male , Female , Child, Preschool , Child , Chemotherapy, Adjuvant , Conjunctival Neoplasms/drug therapy , Interferon alpha-2/therapeutic use , Neoplasm Recurrence, Local/epidemiology , Papillomavirus Infections/drug therapy , Combined Modality Therapy , Conjunctival Neoplasms/surgery , Conjunctival Neoplasms/virology , Cryosurgery , Human papillomavirus 11/isolation & purification , Interferon alpha-2/administration & dosage , Neoplasm Recurrence, Local/prevention & control , Neoplasm Recurrence, Local/virology , Papillomavirus Infections/surgery , Papillomavirus Infections/virologyABSTRACT
A series of paediatric patients is presented in whom topical interferon alpha-2b was used as a co-adjuvant treatment for conjunctival papilloma. This condition is frequently associated with human papillomavirus infection. There is little information on the pediatric population with the use of interferon for the treatment of these lesions. In this case series, adjuvant treatment with topical interferon alpha-2b in paediatric patients showed no recurrence and good tolerance.
